A Long-Term Extension Study of WA22762 and NA25220 of Subcutaneous (SC) Tocilizumab (TCZ) in Moderate to Severe Rheumatoid Arthritis (RA)
Clinical trial NCT01662063 · COMPLETED
Trial details
- NCT number
- NCT01662063
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2014-04-01
- Enrollment
- 218
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.